SCHEMBL4515060

SCHEMBL4515060

c1c[nH]c(CN2CCC2)n1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.85
KAT2B Q92831 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
TAAR1 Q96RJ0 3/20 0.40
HTT P42858 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
PARP1 P09874 1/20 0.39
TERT O14746 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
OPRD1 P41143 1/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
OPRM1 P35372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1953418 0.96 ALOX15 (0.85) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL18325377 0.94 ALOX15 (0.81) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL807358 0.94 ALOX15 (0.81) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL15329166 0.92 ALOX15 (1.00) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL3553264 0.86 ALOX15 (0.69) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL18325474 0.85 ALOX15 (0.67) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL4731563 0.85 ALOX15 (0.79) ALOX15ALDH1A1LMNAHTR1DHTR1B
SCHEMBL6484067 0.85 ALOX15 (0.79) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL5709857 0.85 ALOX15 (0.79) ALOX15KAT2BALDH1A1KDM4ELMNA
SCHEMBL24672614 0.83 ALOX15 (0.82) ALOX15ALDH1A1LMNAHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482374-B2 Pyrrolidine-2-ones as Factor Xa inhibitors GLAXO GROUP LIMITED (GB) 2009-01-27 US disclosed
US-7482374-B2 Pyrrolidine-2-ones as Factor Xa inhibitors GLAXO GROUP LIMITED (GB) 2009-01-27 US disclosed
US-7482374-B2 Pyrrolidine-2-ones as Factor Xa inhibitors GLAXO GROUP LIMITED (GB) 2009-01-27 US disclosed
US-20060167079-A1 Pyrrolidine -2-ones as factor xa inhibitors GLAXO GROUP LIMITED (GB) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167079-A1 Pyrrolidine -2-ones as factor xa inhibitors TFPI, F2, F11 ALOX15 1843/4885KAT2B 1623/4885ALDH1A1 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.